Search results
Jan 12, 2024 · There are many blood thinner medications available to prevent and treat blood clots. Warfarin (Coumadin, Jantoven) is an anticoagulant that’s been around for a long time. Examples of newer oral anticoagulant options include Eliquis (apixaban), Xarelto (rivaroxaban), and Pradaxa (dabigatran).
Nov 12, 2023 · PHILADELPHIA, Nov. 12, 2023 — An experimental anti-clotting medication, abelacimab, significantly reduced bleeding among people with atrial fibrillation (or AFib) who were at risk of stroke, according to results of the AZALEA-TIMI 71 trial, presented today as late-breaking science at the American Heart Association’s Scientific Sessions 2023.
Mar 21, 2024 · A new class of anticoagulant drugs on the horizon is taking fresh aim at one of cardiology’s toughest challenges: how to prevent blood clots that cause heart attacks and strokes, without...
Jun 21, 2021 · June 21, 2021. Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a...
Dec 1, 2019 · New drugs called direct oral anticoagulants (DOACs) are just as effective as warfarin in preventing strokes in people with atrial fibrillation and normal heart valves. For 50 years, warfarin was the only choice for people who needed to take an oral anticoagulant (blood thinner).
Mar 2, 2023 · Bristol Myers Squibb and Johnson & Johnson have begun a series of large studies testing a closely watched experimental blood-thinning medicine, setting plans to include almost 50,000 patients.
Nov 1, 2022 · A large-scale comparison of direct oral anticoagulants (blood thinners), commonly prescribed for irregular heartbeats, has identified the drug with the lowest risk of bleeding, in a new study led by UCL researchers.
